Clinical Trials Logo

Negative Type; Schizophrenic clinical trials

View clinical trials related to Negative Type; Schizophrenic.

Filter by:
  • None
  • Page 1

NCT ID: NCT04793438 Recruiting - Anhedonia Clinical Trials

Motive-specific Intervention for Negative Symptoms in Schizophrenia

MoNSS
Start date: January 1, 2021
Phase: N/A
Study type: Interventional

The aim of this study is to test a therapeutic intervention to reduce negative symptomatic among schizophrenia patients. Since the intervention can take place within an inpatient stay, it is a short intervention. Three appointments are made with the patients within two weeks. With an adaptation of the Autobiographical Memory Test (AMT) participants will be asked to recall events from the past and to imagine future events. Patients are additionally asked to complete tasks between the sessions. One pre- and one post-measurement of negative symptoms, motives, level of functioning, hope for recovery and other co-variables are part of the study. A follow-up appointment four weeks later is intended to provide information on the longer-term impact.

NCT ID: NCT03648268 Completed - Schizophrenia Clinical Trials

Using Transcranial Magnetic Stimulation (TMS) to Understand 'Negative' Symptoms of Schizophrenia

Start date: May 2, 2019
Phase: N/A
Study type: Interventional

The main purpose of this study is to learn how transcranial magnetic stimulation (TMS) helps improve negative symptoms of schizophrenia. These 'negative symptoms' include anhedonia (the inability to enjoy things), low motivation, and decreased facial expression. TMS is a noninvasive way of stimulating the brain. TMS uses a magnetic field to cause changes in activity in the brain. The magnetic field is produced by a coil that is held next to the scalp. In this study we will be stimulating the brain to learn more about how TMS may improve these symptoms from schizophrenia.